Northern Trust Corp Has $52.46 Million Stock Position in Maximus, Inc. $MMS

Key Points

• Northern Trust Corp has reduced its holdings in Maximus, Inc. by 5.6%, selling 45,773 shares, leaving them with approximately 769,360 shares valued at $52.46 million.
• Multiple institutional investors, including Caitong International Asset Management and UMB Bank, significantly increased their stakes in Maximus during the first quarter.
• Maximus recently reported a quarterly earnings per share (EPS) of $2.16, exceeding expectations, and has declared a quarterly dividend of $0.30 per share.

Northern Trust Corp reduced its position in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 5.6% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 769,360 shares of the health services provider's stock after selling 45,773 shares during the period. Northern Trust Corp owned approximately 1.36% of Maximus worth $52,463,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in the company. Dimensional Fund Advisors LP raised its position in Maximus by 20.5% during the first quarter. Dimensional Fund Advisors LP now owns 1,695,582 shares of the health services provider's stock valued at $115,620,000 after purchasing an additional 288,990 shares in the last quarter. Boston Partners acquired a new position in Maximus during the first quarter valued at approximately $20,983,000. Caitong International Asset Management Co. Ltd raised its position in Maximus by 17,533.3% during the first quarter. Caitong International Asset Management Co. Ltd now owns 529 shares of the health services provider's stock valued at $36,000 after purchasing an additional 526 shares in the last quarter. Russell Investments Group Ltd. raised its position in Maximus by 103.5% during the first quarter. Russell Investments Group Ltd. now owns 79,593 shares of the health services provider's stock valued at $5,427,000 after purchasing an additional 40,487 shares in the last quarter. Finally, HighTower Advisors LLC raised its position in Maximus by 61.1% during the first quarter. HighTower Advisors LLC now owns 5,960 shares of the health services provider's stock valued at $406,000 after purchasing an additional 2,261 shares in the last quarter. 97.21% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research analysts have recently issued reports on the stock. Zacks Research upgraded shares of Maximus from a "hold" rating to a "strong-buy" rating in a report on Tuesday, August 26th. Wall Street Zen downgraded shares of Maximus from a "buy" rating to a "hold" rating in a report on Thursday, May 15th. One analyst has rated the stock with a Strong Buy rating and one has issued a Buy rating to the stock. Based on data from MarketBeat, Maximus presently has an average rating of "Strong Buy" and a consensus price target of $90.00.

Maximus Stock Up 0.4%

Shares of NYSE MMS traded up $0.34 during trading on Monday, hitting $88.06. 434,573 shares of the company traded hands, compared to its average volume of 677,149. The business's fifty day moving average is $76.74 and its 200 day moving average is $71.85. Maximus, Inc. has a fifty-two week low of $63.77 and a fifty-two week high of $93.94. The firm has a market capitalization of $4.96 billion, a price-to-earnings ratio of 16.22 and a beta of 0.61. The company has a debt-to-equity ratio of 0.91, a quick ratio of 2.27 and a current ratio of 2.27.

Maximus (NYSE:MMS - Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The health services provider reported $2.16 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.77. Maximus had a net margin of 5.83% and a return on equity of 24.44%. The firm had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.29 billion. During the same quarter in the prior year, the business earned $1.74 earnings per share. The business's quarterly revenue was up 2.5% compared to the same quarter last year. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. Equities research analysts predict that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Sunday, August 31st. Stockholders of record on Friday, August 15th were issued a dividend of $0.30 per share. The ex-dividend date was Friday, August 15th. This represents a $1.20 annualized dividend and a dividend yield of 1.4%. Maximus's dividend payout ratio is currently 22.10%.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.